Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 64.82 CNY -4.11% Market Closed
Market Cap: 48.1B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

Hangzhou Tigermed Consulting Co Ltd
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hangzhou Tigermed Consulting Co Ltd
Cash Peer Comparison

Comparables:
603259
300759
2269
1548
W
2268

Competitive Cash Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cash
ÂĄ3.2B
CAGR 3-Years
3 296%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cash
ÂĄ14.7B
CAGR 3-Years
14%
CAGR 5-Years
581%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cash
ÂĄ2.3B
CAGR 3-Years
2 697%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cash
ÂĄ9.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genscript Biotech Corp
HKEX:1548
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Cash
ÂĄ4B
CAGR 3-Years
422%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hangzhou Tigermed Consulting Co Ltd's Cash?
Cash
3.2B CNY

Based on the financial report for Jun 30, 2024, Hangzhou Tigermed Consulting Co Ltd's Cash amounts to 3.2B CNY.

What is Hangzhou Tigermed Consulting Co Ltd's Cash growth rate?
Cash CAGR 3Y
3 296%

Over the last year, the Cash growth was -61%. The average annual Cash growth rates for Hangzhou Tigermed Consulting Co Ltd have been 3 296% over the past three years .

Back to Top